KM Financial Solutions | Insurance tactic drags down U.S. drug prices in 2nd quarter -analyst
27202
post-template-default,single,single-post,postid-27202,single-format-standard,qode-quick-links-1.0,ajax_fade,page_not_loaded,,qode_grid_1300,footer_responsive_adv,hide_top_bar_on_mobile_header,qode-child-theme-ver-1.0.0,qode-theme-ver-11.2,qode-theme-bridge,wpb-js-composer js-comp-ver-5.2.1,vc_responsive
 

Insurance tactic drags down U.S. drug prices in 2nd quarter -analyst

Insurance tactic drags down U.S. drug prices in 2nd quarter -analyst

U.S. drug prices fell again in
the second quarter, likely due to a new tactic insurers are
using to limit financial assistance drugmakers provide directly
to consumers, according to research firm Sector and Sovereign
Research (SSR).

No Comments

Sorry, the comment form is closed at this time.